drugset / Trial / NCT00010153
ICI 182780 in Treating Women With Stage I or Stage II Primary Breast Cancer
Phase 3
Terminated
European Organisation for Research and Treatment of Cancer - EORTC
Breast International Group · collab
Treatment
Summary
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using ICI 182780 before surgery may block the uptake of estrogen by the tumor cells and prevent metastases. It is not yet known if ICI 182780 is effective in preventing breast cancer metastases. PURPOSE: Randomized phase III trial to study the effectiveness of ICI 182780 given before surgery in treating women who have stage I or stage II primary breast cancer.
Timeline
- Start
- 2000-11
- Primary completion
- 2001-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fulvestrant | Small molecule | — | Intramuscular |